Search

  • HOME
  • Search
Original Articles
Outcomes and Use of Therapeutic Drug Monitoring in Multidrug-Resistant Tuberculosis Patients Treated in Virginia, 2009-2014
Scott K. Heysell, Jane L. Moore, Charles A. Peloquin, David Ashkin, Eric R. Houpt
Tuberc Respir Dis. 2015;78(2):78-84.   Published online April 2, 2015
Full textFull text    PubreaderPubReader    PDFPDF    
A Study on the Mechanism of Immunomodulating Effects of Moxifloxacin in Oleic Acid-Induced Acute Lung Injury.
Young Man Lee
Tuberc Respir Dis. 2011;71(2):97-105.   Published online August 1, 2011
PDFPDF    
Original Articles
Activity of Moxifloxacin Against Ofloxacin-Resistant Mycobacterium Tuberculosis: A Study of Cross-Resistance Between Ofloxacin and Moxifloxacin.
Byoung Ju Kim, Young Soo Kang, Seung Kyu Park
Tuberc Respir Dis. 2004;57(5):405-410.   Published online November 1, 2004
PDFPDF    
A Multicenter, Randomized, Open, Comparative Study for the Efficacy and Safety of Oral Moxifloxacin 400 mg Once a Day and Clarithromycin 500 mg Twice Daily in Korean Patients with Acute Exacerbations of Chronic Bronchitis.
Seung Joon Kim, Seok Chan Kim, Sook Young Lee, Hyeong Kyu Yoon, Tae Yon Kim, Young Kyoon Kim, Jeong Sup Song, Sung Hak Park, Ho Joong Kim, Man Pyo Chung, Gee Young Suh, O Jung Kwon, Shin Hyung Lee, Kyung Ho Kang, Eh Hyung Lee, Sung Chul Hwang, Myung Ho Ha
Tuberc Respir Dis. 2000;49(6):740-751.   Published online December 1, 2000
PDFPDF    

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184



ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next